VRCA Q3 2021 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

VRCAVerrica Pharmaceuticals Inc.

$57M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$111,000

Operating Income

-$12M

Net Income

-$13M

EPS (Diluted)

$-4.66

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$89M

Total Liabilities

$48M

Stockholders' Equity

$41M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$111,000	$0	—
Operating Income	-$12M	-$10M	-22.1%
Net Income	-$13M	-$10M	-22.3%